165 related articles for article (PubMed ID: 35251214)
1. Prognostic Value of Circulating Tumour DNA in Asian Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Liu H; Yang H; Chen X
Evid Based Complement Alternat Med; 2022; 2022():8019652. PubMed ID: 35251214
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
Fan G; Zhang K; Yang X; Ding J; Wang Z; Li J
PLoS One; 2017; 12(2):e0171991. PubMed ID: 28187169
[TBL] [Abstract][Full Text] [Related]
3. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis.
Feng SN; Cen XT; Tan R; Wei SS; Sun LD
Transl Oncol; 2021 Jun; 14(6):101072. PubMed ID: 33744725
[TBL] [Abstract][Full Text] [Related]
5. Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis.
Min L; Chen J; Yu M; Yang K; Liu D
Biomarkers; 2023 Dec; 28(5):427-436. PubMed ID: 37036017
[No Abstract] [Full Text] [Related]
6. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of postoperative ctDNA detection in patients with early non-small cell lung cancer: a systematic review and meta-analysis.
Guo K; Lu J; Lou Y; Zheng S
Ther Adv Med Oncol; 2023; 15():17588359231177008. PubMed ID: 37256023
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis.
Yao L; Xu H; Wo J; Zhao M; Liu Z; Dong T; Xiao S
Clin Exp Med; 2022 Feb; 22(1):1-7. PubMed ID: 33990849
[TBL] [Abstract][Full Text] [Related]
9. Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
Gao Y; Xi H; Wei B; Cui J; Zhang K; Li H; Cai A; Shen W; Li J; Rosell R; Chao J; Chen T; Klempner S; Qiao Z; Chen L
Front Oncol; 2019; 9():1222. PubMed ID: 31850190
[No Abstract] [Full Text] [Related]
10. An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
Zhang Y; Du H; Wang N; Wang L; Huang Y
BMC Cancer; 2024 Jan; 24(1):129. PubMed ID: 38267901
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of ctDNA Mutation in Melanoma: A Meta-Analysis.
Zheng Y; Sun H; Cong L; Liu C; Sun Q; Wu N; Cong X
J Oncol; 2021; 2021():6660571. PubMed ID: 34035810
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
Lu Y; Li L
Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
[No Abstract] [Full Text] [Related]
14. The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer.
Wei J; Feng J; Weng Y; Xu Z; Jin Y; Wang P; Cui X; Ruan P; Luo R; Li N; Peng M
Front Oncol; 2021; 11():706910. PubMed ID: 34660274
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Lee JS; Rhee TM; Pietrasz D; Bachet JB; Laurent-Puig P; Kong SY; Takai E; Yachida S; Shibata T; Lee JW; Park HC; Zang DY; Jeon K; Lee J; Kim M; Kim HS; Kang HJ; Lee YK
Sci Rep; 2019 Nov; 9(1):16971. PubMed ID: 31740696
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
Wullaert L; van Rees JM; Martens JWM; Verheul HMW; Grünhagen DJ; Wilting SM; Verhoef C
Cells; 2023 Oct; 12(21):. PubMed ID: 37947598
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis.
Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J
Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis.
Vidal L; Pando E; Blanco L; Fabregat-Franco C; Castet F; Sierra A; Macarulla T; Balsells J; Charco R; Vivancos A
Cancer Treat Rev; 2023 Nov; 120():102604. PubMed ID: 37572593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
